Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Alpha-Mannosidosis to Genetic Disorders Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Alpha-Mannosidosis to Genetic Disorders Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Alpha-Mannosidosis Therapeutics Clinical Trials 23
Prominent Drugs 24
Clinical Trial Profile Snapshots 25
Appendix 35
Abbreviations 35
Definitions 35
Research Methodology 36
Secondary Research 36
About GlobalData 37
Contact Us 37
Source 37

List of Tables
Alpha-Mannosidosis Therapeutics, Global, Clinical Trials by Region, 2017* 6
Alpha-Mannosidosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Alpha-Mannosidosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Alpha-Mannosidosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Alpha-Mannosidosis Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Proportion of Alpha-Mannosidosis to Genetic Disorders Clinical Trials, G7 Countries (%), 2017* 12
Alpha-Mannosidosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 13
Alpha-Mannosidosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 14
Proportion of Alpha-Mannosidosis to Genetic Disorders Clinical Trials, E7 Countries (%), 2017* 15
Alpha-Mannosidosis Therapeutics, Global, Clinical Trials by Phase, 2017* 16
Alpha-Mannosidosis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 17
Alpha-Mannosidosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 18
Alpha-Mannosidosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 19
Alpha-Mannosidosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 20
Alpha-Mannosidosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 21
Alpha-Mannosidosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 22
Alpha-Mannosidosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 23
Alpha-Mannosidosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 24

List of Figures
Alpha-Mannosidosis Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Alpha-Mannosidosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Alpha-Mannosidosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Alpha-Mannosidosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Proportion of Alpha-Mannosidosis to Genetic Disorders Clinical Trials, G7 Countries (%), 2017* 12
Alpha-Mannosidosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 13
Alpha-Mannosidosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 14
Proportion of Alpha-Mannosidosis to Genetic Disorders Clinical Trials, E7 Countries (%), 2017* 15
Alpha-Mannosidosis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 16
Alpha-Mannosidosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 17
Alpha-Mannosidosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 18
Alpha-Mannosidosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 19
Alpha-Mannosidosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 20
Alpha-Mannosidosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 21
Alpha-Mannosidosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 22
Alpha-Mannosidosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 23
Alpha-Mannosidosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 24
GlobalData Methodology 36

Companies Mentioned
Chiesi Farmaceutici SpA
Zymenex A/S
Larix A/S
Nuo Therapeutics Inc
Fate Therapeutics Inc
Cromsource Srl